Maria Alexakis
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Maria Alexakis
Medical Affairs Director / AusCann Group Holdings
Maria Alexakis has over 20 years of experience in business development, strategic planning and execution of complex plans within the consumer, pharmaceutical, medical devices and medicinal cannabis industries. Her career has spanned research and product development as well as commercial roles in sales, marketing and product education.
She has worked at diversified global healthcare companies including Johnson and Johnson, Sanofi Aventis, Pfizer and Astra Zeneca, as well as more locally focused companies such as Australasian Medical and Scientific, EBOS and Hahn Healthcare.
Ms Alexakis holds a Bachelor of Science (Chemistry) from Macquarie University.
She has worked at diversified global healthcare companies including Johnson and Johnson, Sanofi Aventis, Pfizer and Astra Zeneca, as well as more locally focused companies such as Australasian Medical and Scientific, EBOS and Hahn Healthcare.
Ms Alexakis holds a Bachelor of Science (Chemistry) from Macquarie University.
Lists and Charts
Total Shareholder Return as at 31/05/22
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| th | Zimi | -68% | -38% |
| 725th | Wellfully | 1% | -0% |
| 1412th | Rare Foods Australia | -38% | |
| 1614th | AusCann Group Holdings | -52% | -32% |
| 1855th | InteliCare | -75% |
1818 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Rare Foods Australia | $5.1m |
| 144th |  | AusCann Group Holdings | $1.8m |
| 160th |  | Zimi | $928k |
| 161st | | InteliCare | $927k |
| 164th | | Wellfully | $1.2m |
207 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
 | NEW ROLE: Medical Affairs Director, AusCann Group Holdings | 22 Feb 2021 |
